KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Depreciation & Amortization (CF) (2016 - 2025)

National Health Investors (NHI) has disclosed Depreciation & Amortization (CF) for 16 consecutive years, with $20.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation & Amortization (CF) rose 13.78% year-over-year to $20.2 million, compared with a TTM value of $59.3 million through Dec 2025, down 17.01%, and an annual FY2025 reading of $80.9 million, up 13.3% over the prior year.
  • Depreciation & Amortization (CF) was $20.2 million for Q3 2025 at National Health Investors, up from $19.9 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $20.8 million in Q1 2021 and bottomed at $17.1 million in Q4 2023.
  • Average Depreciation & Amortization (CF) over 5 years is $18.5 million, with a median of $17.8 million recorded in 2022.
  • The sharpest move saw Depreciation & Amortization (CF) dropped 13.97% in 2022, then grew 13.88% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $19.3 million in 2021, then fell by 10.34% to $17.3 million in 2022, then dropped by 1.11% to $17.1 million in 2023, then grew by 9.17% to $18.7 million in 2024, then grew by 8.22% to $20.2 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for NHI at $20.2 million in Q3 2025, $19.9 million in Q2 2025, and $19.2 million in Q1 2025.